Author

Josipa Budimir

Institution: Opća bolnica Šibenik

Observed institution: Opća bolnica Šibenik

ORCID: 0009-0002-5956-4137

Observed ORCID: 0009-0002-5956-4137

OpenAlex ID: A5049878907

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis

2024 · Marko Lucijanic, Ivan Krecak, et al. · Life · 10

Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis

2024 · Marko Lucijanic, Ivan Krecak, et al. · Annals of Hematology · 8

Diabetes mellitus, metformin, and the risk of MPN

2024 · Ivan Krecak, Sanja Klobucar, et al. · Blood Advances · 3

Differentiating polycythemia vera from sodium-glucose cotransporter 2 inhibitor-associated polycythemia

2026 · Ivan Krecak, Marija Valovicic Krecak, et al. · Acta Diabetologica · 1

High lymphocyte count and bleeding risk in patients with chronic lymphocytic leukemia treated with Bruton’s tyrosine kinase inhibitors

2025 · Ivan Krečak, Bruna Kvinta, et al. · Wiener klinische Wochenschrift · 1

Fecal calprotectin as a biomarker of intestinal inflammation in patients with myeloproliferative neoplasms

2026 · Ivan Krecak, Iva Sesar Mrkela, et al. · Scandinavian Journal of Clinical and Laboratory Investigation

Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment

2026 · Ivan Krecak, Josipa Budimir, et al. · Expert Review of Hematology

Plateletcrit and the Risk of Bleeding in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated with Bruton's Tyrosine Kinase Inhibitors

2024 · Ivan Krecak, Marina Paladin, et al. · Blood

Systemic mastocytosis in Croatia

2022 · Ivan Krečak, Pavle Rončević, et al. · Liječnički vjesnik

Works count: 9

Citation count: 23

H-index: 3

I10-index: 1